Zhang Xue-zhong, Xu Yan-li, Jin Juan, Zhang Xiu-qun, Zhang Lei, Su Ai-ling
Depatment of Hematology, The First Hospital Affiliated to Nanjing Medical University, Nanjing 210006, China.
Chin J Integr Med. 2006 Jun;12(2):142-5. doi: 10.1007/BF02857362.
To explore the therapy to further elevate the efficacy of the treatment of chronic aplastic anemia (CAA).
Forty-five patients with CCA were assigned into two groups, the 26 patients in the treated group were treated by Shengxuening (a Chinese herbal preparation) and cyclosporin A (CsA), and the 19 patients in the control group were treated with androgen alone, with the therapeutic course lasting for over 3 months. Changes of peripheral blood picture, and the colony productivity of burst forming unit-erythroid (BFU-E), colony forming unit-erythroid (CFU-E) and colony forming unit-granulocyte macrophage (CFU-GM) in bone marrow were observed before and after 3 months treatment. The amount of erythrocyte and platelet infusion, frequency of infection, condition of hemorrhage and relevant death were also observed. The follow-up study was conducted for over half a year.
The total effective rate in the treated group was 84.6%, which was significantly higher than that in the control group (52.6%, P < 0.05). Levels of hemoglobin, reticulocyte, neutrophil and platelet increased after treatment in the treated group, as compared with those before treatment, with significant difference (P < 0.05), and the colony productivity of BFU-E, CFU-E and CFU-GM in bone marrow also got significantly increased (P < 0.01), and showed significant difference from those in the control group (P < 0.05).
Shengxuening-assisting CsA therapy is an effective measure for treatment of CAA.
探讨进一步提高慢性再生障碍性贫血(CAA)治疗效果的疗法。
45例CAA患者分为两组,治疗组26例,采用升血宁(一种中药制剂)联合环孢素A(CsA)治疗;对照组19例,单纯使用雄激素治疗,疗程均超过3个月。观察治疗3个月前后外周血象变化及骨髓中红系爆式集落形成单位(BFU-E)、红系集落形成单位(CFU-E)和粒-巨噬系集落形成单位(CFU-GM)的集落生成能力。同时观察红细胞及血小板输注量、感染频率、出血情况及相关死亡情况。进行半年以上的随访研究。
治疗组总有效率为84.6%,显著高于对照组(52.6%,P<0.05)。治疗组治疗后血红蛋白、网织红细胞、中性粒细胞及血小板水平较治疗前升高,差异有统计学意义(P<0.05),骨髓中BFU-E、CFU-E及CFU-GM的集落生成能力也显著增强(P<0.01),与对照组比较差异有统计学意义(P<0.05)。
升血宁辅助CsA治疗是治疗CAA的有效措施。